The goal of this study was to design and produce a novel fusion protein (F8IL15Rα), consisting of the F8 antibody in diabody format fused to the extracellular portion of mouse IL15Rα, with the plan to non-covalently assemble the product with recombinant IL15 and use the resulting complex for tumour targeting applications. This evidence concerns the gene IL15 and neoplasm.